VOICES FROM THE INDUSTRY: Patent ruling a big victory for biotech, drug industries

Last Halloween a federal court in Virginia gave the biotech and pharmaceutical industries a big treat when it preliminarily halted the Patent and Trademark Office, or PTO, from implementing new rules governing certain aspects of patent prosecution. This ruling was significant because it prevented the PTO from imple menting new rules governing patent applications that many thought would weaken protection of important biological and chemical inventions. Several local life sciences businesses and entities with significant numbers of patent applications in…

Read More